Physician

Alan Paul Koterba, M.D.

According to 2025 Medicare claims, Alan Koterba, M.D. (NPI: 1609994458) practices allergy/immunology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is INSTITUTE FOR ASTHMA AND ALLERGY P.C. (NPI: 1447341110; TIN: 521984329) and primary practice location at 33408-9998. Koterba is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Koterba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 8,745 HCPCS/CPT codes, and received $237,630 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 993 prescription claims across 221 beneficiaries totaling $582,946 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 1,367 claims. Open Payments data shows 79 records totaling $2,076. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,501,696 to $237,630. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $147,966 to $582,946. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	53,725	$1,501,696
2016	534	65,838	$1,587,078
2017	560	72,235	$1,588,214
2018	634	51,644	$1,182,636
2019	704	66,941	$1,402,744
2020	580	54,721	$1,495,762
2021	560	59,284	$1,737,309
2022	530	54,508	$1,532,052
2023	520	41,451	$1,321,120
2024	508	8,745	$237,630

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	316	980	$147,966
2016	262	998	$137,851
2017	259	1,088	$256,493
2018	299	1,039	$370,205
2019	382	1,710	$365,981
2020	363	1,840	$484,131
2021	316	1,583	$647,247
2022	272	1,141	$634,671
2023	243	1,008	$351,055
2024	221	993	$582,946

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	230	$302,435
2016	N/R	325	$400,732
2017	44	801	$918,883
2018	136	988	$1,097,727
2019	106	1,338	$1,548,227
2020	85	1,571	$1,690,276
2021	106	1,224	$1,503,458
2022	75	1,200	$1,530,616
2023	72	1,126	$1,679,968
2024	120	1,367	$2,256,997

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	98	98	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	119	161	$106
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	80	80	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	292	474	$74
95117	Professional service for multiple injections of allergen	57	288	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	38	1,176	$156,436
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	26	728	$97,833
Dupixent Syringe	Dupilumab	17	476	$67,478
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	2,760	$58,829
Nucala	Mepolizumab	12	336	$51,363

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	12	138	$569,899
J1559	Injection, immune globulin (hizentra), 100 mg	N	17	127	$486,645
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	13	124	$358,384
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	53	$140,799
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	54	$139,521

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$2,076	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Paul Koterba, M.D.?

Tedicare shows public-source Medicare data for Alan Paul Koterba, M.D. (NPI 1609994458), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Paul Koterba, M.D. have ACO affiliation data?

Alan Paul Koterba, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Alan Paul Koterba, M.D.?

Alan Paul Koterba, M.D. is linked to INSTITUTE FOR ASTHMA AND ALLERGY P.C. (billing NPI 1447341110) in the available physician profile data.

Does Alan Paul Koterba, M.D. have Open Payments data?

Alan Paul Koterba, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.